[
    {
        "symbol": "BEAM",
        "price": 24.25,
        "beta": 2.251,
        "volAvg": 2649029,
        "mktCap": 2453179131,
        "lastDiv": 0,
        "range": "13.525-35.25",
        "changes": -0.76,
        "companyName": "Beam Therapeutics Inc.",
        "currency": "USD",
        "cik": "0001745999",
        "isin": "US07373V1052",
        "cusip": "07373V105",
        "exchange": "NASDAQ Global Select",
        "exchangeShortName": "NASDAQ",
        "industry": "Biotechnology",
        "website": "https://www.beamtx.com",
        "description": "Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-301, a liver-targeted development candidate for the treatment of patients with Glycogen Storage Disease Type Ia. It also develops therapies for alpha-1 antitrypsin deficiency; ocular diseases; and other liver, muscle, and central nervous system disorders. The company has an alliance with Boston Children's Hospital; a research and clinical trial collaboration agreement with Magenta Therapeutics, Inc.; license agreement with Sana Biotechnology, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration agreement with Pfizer Inc. and Apellis Pharmaceuticals, Inc.; and collaboration and license agreement with Verve Therapeutics, Inc. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.",
        "ceo": "John M. Evans",
        "sector": "Healthcare",
        "country": "US",
        "fullTimeEmployees": "393",
        "phone": "857 327 8775",
        "address": "238 Main Street",
        "city": "Cambridge",
        "state": "MA",
        "zip": "02142",
        "dcfDiff": 49.52188,
        "dcf": -24.511883567581748,
        "image": "https://images.financialmodelingprep.com/symbol/BEAM.png",
        "ipoDate": "2020-02-06",
        "defaultImage": false,
        "isEtf": false,
        "isActivelyTrading": true,
        "isAdr": false,
        "isFund": false
    }
]